These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34992593)

  • 1. The Role of Heparin and Glycocalyx in Blood-Brain Barrier Dysfunction.
    Yang R; Chen M; Zheng J; Li X; Zhang X
    Front Immunol; 2021; 12():754141. PubMed ID: 34992593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implication of the blood-brain barrier in neurological diseases: part II].
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Rev Neurol (Paris); 2009 Dec; 165(12):1010-22. PubMed ID: 19487004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin ameliorates cerebral edema and improves outcomes following status epilepticus by protecting endothelial glycocalyx in mice.
    Li X; Zhu J; Liu K; Hu Y; Huang K; Pan S
    Exp Neurol; 2020 Aug; 330():113320. PubMed ID: 32305420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycocalyx is critical for blood-brain barrier integrity by suppressing caveolin1-dependent endothelial transcytosis following ischemic stroke.
    Zhu J; Li Z; Ji Z; Wu Y; He Y; Liu K; Chang Y; Peng Y; Lin Z; Wang S; Wang D; Huang K; Pan S
    Brain Pathol; 2022 Jan; 32(1):e13006. PubMed ID: 34286899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood-brain barrier in brain homeostasis and neurological diseases.
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Biochim Biophys Acta; 2009 Apr; 1788(4):842-57. PubMed ID: 19061857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial glycocalyx as an important factor in composition of blood-brain barrier.
    Zhao F; Zhong L; Luo Y
    CNS Neurosci Ther; 2021 Jan; 27(1):26-35. PubMed ID: 33377610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure.
    Ko K; Suzuki T; Ishikawa R; Hattori N; Ito R; Umehara K; Furihata T; Dohmae N; Linhardt RJ; Igarashi K; Toida T; Higashi K
    J Biol Chem; 2020 Dec; 295(52):18614-18624. PubMed ID: 33127645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the blood-brain barrier during neurological disease and infection.
    Patabendige A; Janigro D
    Biochem Soc Trans; 2023 Apr; 51(2):613-626. PubMed ID: 36929707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model.
    Santa-Maria AR; Walter FR; Figueiredo R; Kincses A; Vigh JP; Heymans M; Culot M; Winter P; Gosselet F; Dér A; Deli MA
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2201-2215. PubMed ID: 33563079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice.
    VanTeeffelen JW; Brands J; Jansen C; Spaan JA; Vink H
    Hypertension; 2007 Jul; 50(1):261-7. PubMed ID: 17452501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelial glycocalyx: the great luminal barrier.
    Kolsen-Petersen JA
    Acta Anaesthesiol Scand; 2015 Feb; 59(2):137-9. PubMed ID: 25597986
    [No Abstract]   [Full Text] [Related]  

  • 12. Protocol for intraoperative assessment of the human cerebrovascular glycocalyx.
    Haeren RH; Vink H; Staals J; van Zandvoort MA; Dings J; van Overbeeke JJ; Hoogland G; Rijkers K; Schijns OE
    BMJ Open; 2017 Jan; 7(1):e013954. PubMed ID: 28057660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blood-brain barrier in neuroinflammatory diseases.
    de Vries HE; Kuiper J; de Boer AG; Van Berkel TJ; Breimer DD
    Pharmacol Rev; 1997 Jun; 49(2):143-55. PubMed ID: 9228664
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.
    Gurnik S; Devraj K; Macas J; Yamaji M; Starke J; Scholz A; Sommer K; Di Tacchio M; Vutukuri R; Beck H; Mittelbronn M; Foerch C; Pfeilschifter W; Liebner S; Peters KG; Plate KH; Reiss Y
    Acta Neuropathol; 2016 May; 131(5):753-73. PubMed ID: 26932603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats.
    Zhu J; Li X; Yin J; Hu Y; Gu Y; Pan S
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):1979-1992. PubMed ID: 28825336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.
    Ostrowski SR; Johansson PI
    J Trauma Acute Care Surg; 2012 Jul; 73(1):60-6. PubMed ID: 22743373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx.
    Dull RO; Dinavahi R; Schwartz L; Humphries DE; Berry D; Sasisekharan R; Garcia JG
    Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L986-95. PubMed ID: 12754183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Nervous System Lymphatics and Impact on Neurologic Disease.
    Nistal D; Mocco J
    World Neurosurg; 2018 Jan; 109():449-450. PubMed ID: 29138077
    [No Abstract]   [Full Text] [Related]  

  • 19. The Structure and Function of the Glycocalyx and Its Connection With Blood-Brain Barrier.
    Jin J; Fang F; Gao W; Chen H; Wen J; Wen X; Chen J
    Front Cell Neurosci; 2021; 15():739699. PubMed ID: 34690703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shengui Sansheng Pulvis maintains blood-brain barrier integrity by vasoactive intestinal peptide after ischemic stroke.
    Xia ZY; Luo C; Liu BW; Bian XQ; Li Y; Pang AM; Xu YH; Tan HM; Zhao YH
    Phytomedicine; 2020 Feb; 67():153158. PubMed ID: 31999981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.